Review of WELL Health Technologies

SEP 03, 2021 - We like WELL’s strategy, management, growth trajectory, and sector. The telehealth frenzy last year expanded multiples at a much faster pace than expected. Regardless, WELL trades at a significant discount compared to US peers in telehealth. Rating maintained at ‘B+’

Download Report

Q: I'm 50% down on both of these companies. I'm ready to throw in the towel on either if not both. Do you believe they will recover in the next 2 years? Would you rather sell one and buy the other, would you just hold for now, or would you sell both and buy something else? Take as many credits as needed. Thanks

Read Answer Asked by Ziaad on July 07, 2022

Q: Can you discuss why these two keep dropping and projections for the future. Many thanks.

Read Answer Asked by Michael on July 05, 2022

Q: If you didn't own any of these stocks would you feel comfortable in buying full positions today.

Read Answer Asked by Steve on July 05, 2022